Activation of antigen-induced lymphocyte proliferation by interleukin- 15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression

Journal of Clinical Investigation

Volumn 98, Issue 3, 1996, Pages 616-621

  Patki, Abhay H ^a   Quiñones Mateu, Miguel E ^a,d   Dorazio, Dominic ^a   Yen Lieberman, Belinda ^b   Boom, W Henry ^a   Thomas, Elaine K ^c   Lederman, Michael M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c AMGEN INC   (United States)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

cellular proliferation; cytokines; HIV; human; T lymphocytes

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 2;

ARTICLE; CELL CULTURE; DOSE RESPONSE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MITOGENICITY; PRIORITY JOURNAL; VIRUS EXPRESSION;

EID: 0029862274     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118831     Document Type: Article

References (14)

1. Grabstein, K.H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. Schoenborn, M. Ahdieh, et al. 1994. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science (Wash. DC). 264:965-968.
2. Gruters, R.A., F.G. Terpstra, R. De Jong, C.J.M. Van Noesel, R.A.W. Van Lier, and F. Miedema. 1990. Selective loss of T cell function in different stages of HIV infection: early loss of anti-CD-3-induced T cell proliferation followed by decreased anti-CD-3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS. Eur. J. Immunol. 20:1039-1044.
3. + T helper cell depletion occurs. J. Clin. Invest. 82:1908-1914.
4. Lane, H.C., J.M. Depper, W.C. Greene, G. Whalen, T.A. Waldmann, and A.S. Fauci. 1985. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N. Engl. J. Med. 313:79-84.
5. Shearer, G.M., D.C. Bernstein, K.S.K. Tung, C.S. Via, R. Redfield, S.Z. Salahuddin, and R.C. Gallo. 1986. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J. Immunol. 137: 2514-2521.
6. Fan, J., H.Z. Bass, and J.L. Fahey. 1993. Elevated IFN-γ and decreased IL-2 gene expression are associated with HIV infection. J. Immunol. 151:5031-5040.
7. Rook, A.H., H. Masur, H.C. Lane, W. Frederick, T. Kasahara, A.M. Macher, J.Y. Dieu, J.F. Manischewitz, L. Jackson, A.S. Fauci, and G.V. Quinnan, 1983. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes obtained from patients with the acquired immunodeficiency syndrome. J. Clin. Invest. 72:398-403.
8. Bell, S.J.D., D.A. Cooper, B.E. Kemp, R.R. Doherty, and R. Penny. 1992. Heterogenous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI). Clin. Exp. Immunol. 90:6-12.
9. Berzofsky, J.A., C.D. Pendleton, M. Clerici, J. Ahlers, D.R. Lucey, S.D. Putney, and G.M. Shearer. 1991. Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope in induce in vitro T cell responses in mice and humans of multiple MHC types. J. Clin. Invest. 88:876-884.
10. Kovacs, J.A., M. Baseler, R. Dewar, S. Vogal, R.T. Davey, J. Fallonn, M.A. Polis, R.E. Walker, R. Stevens, N.P. Salzman, et al. 1995. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection: a preliminary study. N. Engl. J. Med. 332:567-575.
11. Mudido, P., D. Georges, D. Dorazio, W.A. O'Brien, and M.M. Lederman. 1994. Blood transfusion activates HIV-1 expression. ICAAC. 1126:130a. (Abstr.)
12. Seder, R.A., K.H. Grabstein, J.A. Berzofsky, and J.F. McDyer. 1995. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of Interleukin IL-2, IL-12, and IL-15. J. Exp. Med. 182:1067-1078.
13. + T cells and this effect overrides its ability to stimulate virus expression. Proc. Natl. Acad. Sci. USA. 92:10985-10999.
14. Lane, H.C. 1995. Immunologic approaches to the therapy of HIV infection. International Symposium on Clinical Immunology: HIV symposium. Clinical Immunology Society. 3 (Abstr).